Rivex Pharma Inc is the drug distribution division of Helix. The company has its own drug registrations and acts as Canadian distributor for a variety of European and American pharmaceutical companies. Rivex also provides Regulatory and Clinical services for these companies as well as a full compliment of Sales, Marketing and Logistics activities.

Gastroenterology is a key therapeutic area for the company with products for bowel lavage, Irritable Bowel Syndrome, lactose intolerance as well as a natural bulk forming laxative. The area of Immunology presents unique opportunities for Rivex as there is increasing focus on immunomodulatory drugs as a possible way to treat immune based diseases such as Chronic Fatigue Syndrome and Fibromyalgia. These therapeutic segments offer an ideal niche opportunity for the company to promote its products.

Osteoarthritis is another major focus for Rivex. It is estimated that greater than 5% of the worlds population is affected by Osteoarthritis of the knee. Conventional treatment methods such as Weight loss, pain medication, and intra-articular steroids simply mask the pain caused by Osteoarthritis. Orthovisc® represents a safe, convenient, nonsurgical treatment for Osteoarthritis that not only reduces pain but also may prevent further damage.